Publicación:
Expresión de Osteopontina y Ciclooxigenasa-2 en relación con la proliferación celular, en mucosa colónica no tumoral, adenomas y adenocarcinoma de colon.

Vista sencilla de ítem
dc.contributor.authorBenedetti Padron, Inésspa
dc.contributor.authorLecompte Osorio, Paolaspa
dc.contributor.authorBarrios Garcia, Líaspa
dc.date.accessioned2021-01-15 00:00:00
dc.date.available2021-01-15 00:00:00
dc.date.issued2021-01-15
dc.format.mimetypeapplication/pdfeng
dc.identifier.doi10.32997/rcb-2021-3232
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urlhttps://doi.org/10.32997/rcb-2021-3232
dc.language.isoengeng
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3232/2745
dc.relation.citationeditionNúm. 1 , Año 2021spa
dc.relation.citationendpage15
dc.relation.citationissue1spa
dc.relation.citationstartpage3
dc.relation.citationvolume10spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesFerlay J CM, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019; 144(8): 1941-53. https://doi.org/10.1002/ijc.31937eng
dc.relation.referencesCampo-Sánchez S, Camargo-Trillos J, Calle-Ramírez J, Gómez-Wolff L, Sánchez-Patiño L, García-García H. Supervivencia de cáncer colorrectal en un centro oncológico de Colombia. Estudio de cohorte histórica. Revista de Gastroenterología de México. 2018. https://doi.org/10.1016/j.rgmx.2018.04.002eng
dc.relation.referencesGiráldez MD. Avances en la etiopatogenia, identificación y manejo clínico de las formas hereditarias y familiares de cáncer colorrectal. Gastroenterología y Hepatología. 2011; 34: 70-5. https://doi.org/10.1016/S0210-5705(11)70011-5eng
dc.relation.referencesFearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5): 759-67. https://doi.org/10.1016/0092-8674(90)90186-Ieng
dc.relation.referencesMarmol I, Sanchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci. 2017; 18(1). https://doi.org/10.3390/ijms18010197eng
dc.relation.referencesArmaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointestinal cancer research: GCR. 2012; 5(1): 19.eng
dc.relation.referencesNiitsu H, Hinoi T, Kawaguchi Y, Sentani K, Yuge R, Kitadai Y, et al. KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer. Oncogenesis. 2016; 5(8): e253. https://doi.org/10.1038/oncsis.2016.47eng
dc.relation.referencesLeslie A, Carey F, Pratt N, Steele R. The colorectal adenoma-carcinoma sequence. British Journal of Surgery. 2002; 89(7): 845-60. https://doi.org/10.1046/j.1365-2168.2002.02120.xeng
dc.relation.referencesBenedetti-Padrón I, Becerra-Mejía D. Expresión de Ciclooxigenasa-2 en carcinoma colorrectal, una revisión narrativa. Iatreia. 2019; 32(1): 52-63. https://doi.org/10.17533/udea.iatreia.v32n1a06eng
dc.relation.referencesKoehne C-H, Dubois RN, editors. COX-2 inhibition and colorectal cancer. Seminars in oncology; 2004: Elsevier. https://doi.org/10.1053/j.seminoncol.2004.03.041eng
dc.relation.referencesSoslow RA, Dannenberg AJ, Rush D, Woerner B, Khan KN, Masferrer J, et al. COX‐2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 2000; 89(12): 2637-45. https://doi.org/10.1002/1097-0142(20001215)89:122637::AID-CNCR173.0.CO;2-Beng
dc.relation.referencesDi Bartolomeo M, Pietrantonio F, Pellegrinelli A, Martinetti A, Mariani L, Daidone MG, et al. Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer. Gastric cancer. 2016; 19(2): 412-20. https://doi.org/10.1007/s10120-015-0495-yeng
dc.relation.referencesWei R, Wong JPC, Lyu P, Xi X, Tong O, Zhang SD, et al. In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer. Journal of Cellular and Molecular Medicine. 2018; 22(9): 4097-105. https://doi.org/10.1111/jcmm.13686eng
dc.relation.referencesBecerra D, Benedetti I. OSTEOPONTINA, UNA PROTEÍNA INVOLUCRADA EN LA PROGRESIÓN TUMORAL, Y SU PARTICIPACIÓN EN EL DESARROLLO DEL CARCINOMA COLORRECTAL. Revista Ciencias Biomédicas. 2019; 8(1): 15-21. https://doi.org/10.32997/rcb-2018-2711eng
dc.relation.referencesZubiaurre L, de Pierola LBF. Aspirina en la prevención del cáncer colorrectal. Gastroenterología y Hepatología. 2011; 34(5): 337-45. https://doi.org/10.1016/j.gastrohep.2011.01.004eng
dc.relation.referencesKale S, Raja R, Thorat D, Soundararajan G, Patil TV, Kundu GC. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via alpha9beta1 integrin. Oncogene. 2014; 33(18): 2295-306. https://doi.org/10.1038/onc.2013.184eng
dc.relation.referencesJain S, Chakraborty G, Kundu GC. The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis. Cancer Res. 2006; 66(13): 6638-48. https://doi.org/10.1158/0008-5472.CAN-06-0661eng
dc.relation.referencesWasilewicz MP, Kołodziej B, Bojułko T, Kaczmarczyk M, Sulzyc-Bielicka V, Bielicki D. Expression of cyclooxygenase-2 in colonic polyps. Pol Arch Med Wewn. 2010; 120(9): 313-20. https://doi.org/10.20452/pamw.955eng
dc.relation.referencesLi J, Yang G-Z, Zhu Z-M, Zhou Z-Y, Li L. Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistry. Experimental and therapeutic medicine. 2012; 3(4): 621-4. https://doi.org/10.3892/etm.2012.465eng
dc.relation.referencesPetrişor O, Giuşcă SE, Sajin M, Dobrescu G, Căruntu I-D. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma. Rom J Morphol Embryol. 2008; 49(2): 163-71.eng
dc.relation.referencesMelling N, Kowitz CM, Simon R, Bokemeyer C, Terracciano L, Sauter G, et al. High Ki67 expression is an independent good prognostic marker in colorectal cancer. Journal of clinical pathology. 2016; 69(3): 209-14. https://doi.org/10.1136/jclinpath-2015-202985eng
dc.relation.referencesÁvila FP, Ortega GC, García RM. Marcadores inmunohistoquímicos p53 y Ki67: utilización diagnóstica y pronóstica en el cáncer de colon. Revista andaluza de patología digestiva. 2012; 35(3): 173-8.eng
dc.relation.referencesMesina C, Stoean LC, Stoean R, Sandita VA, Gruia CL, Foarfa MC, et al. Immunohistochemical Expression of CD8, CDX2, P53, D2-40 and KI 67 in Colorectal Adenocarcinoma, Conventional and Malignant Colo-rectal Polyps. Bucharest. 2018; 69: 419. https://doi.org/10.37358/RC.18.2.6120eng
dc.relation.referencesLi L, Wang J, Jian'gang Li ZW, Ma P. Expression of Ki-67 and pAKT in colorectal cancer tissues and their clinical significance. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. 2018; 11(5): 4623-30.eng
dc.relation.referencesTorlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). The American journal of surgical pathology. 2008; 32(1): 21-9. https://doi.org/10.1097/PAS.0b013e318157f002eng
dc.relation.referencesSakuma K, Fujimori T, Hirabayashi K, Terano A. Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer. Journal of gastroenterology. 1999; 34(2): 189-94. https://doi.org/10.1007/s005350050242eng
dc.relation.referencesEberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994; 107(4): 1183-8. https://doi.org/10.1016/0016-5085(94)90246-1eng
dc.relation.referencesSano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, et al. Expression of cyclooxygenase-1 and-2 in human colorectal cancer. Cancer research. 1995; 55(17): 3785-9. https://doi.org/10.1016/0928-4680(94)90594-0eng
dc.relation.referencesLim SC, Lee TB, Choi CH, Ryu SY, Min YD, Kim KJ. Prognostic significance of cyclooxygenase‐2 expression and nuclear p53 accumulation in patients with colorectal cancer. Journal of surgical oncology. 2008; 97(1): 51-6. https://doi.org/10.1002/jso.20907eng
dc.relation.referencesYamac D, Celenkoglu G, Coskun U, Akyurek N, Akcali Z, Dursun A, et al. Prognostic importance of COX-2 expression in patients with colorectal cancer. Pathology-Research and Practice. 2005; 201(7): 497-502. https://doi.org/10.1016/j.prp.2005.04.006eng
dc.relation.referencesSobolewski C, Cerella C, Dicato M, Ghibelli L, Diederich M. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. International journal of cell biology. 2010; 2010. https://doi.org/10.1155/2010/215158eng
dc.relation.referencesLamort AS, Giopanou I, Psallidas I, Stathopoulos GT. Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight. Cells. 2019; 8(8). https://doi.org/10.3390/cells8080815eng
dc.relation.referencesHao C, Cui Y, Owen S, Li W, Cheng S, Jiang WG. Human osteopontin: Potential clinical applications in cancer (Review). Int J Mol Med. 2017; 39(6): 1327-37. https://doi.org/10.3892/ijmm.2017.2964eng
dc.relation.referencesCoppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clinical cancer research. 2004; 10(1): 184-90. https://doi.org/10.1158/1078-0432.CCR-1405-2eng
dc.relation.referencesWei R, Wong JPC, Kwok HF. Osteopontin--a promising biomarker for cancer therapy. Journal of Cancer. 2017; 8(12): 2173. https://doi.org/10.7150/jca.20480eng
dc.relation.referencesYoussef NS, Osman WM. Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma. International journal of clinical and experimental pathology. 2015; 8(2): 1503.eng
dc.relation.referencesCheng Y, Wen G, Sun Y, Shen Y, Zeng Y, Du M, et al. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3beta-beta/Catenin Pathway. Med Sci Monit. 2019; 25: 3014-25. https://doi.org/10.12659/MSM.913185eng
dc.rightsInés Benedetti Padron - 2021eng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesseng
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2eng
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.eng
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/eng
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3232eng
dc.subjectColorectal cancereng
dc.subjectOsteopontineng
dc.subjectCyclooxygenase-2eng
dc.subjectCáncer colorrectalspa
dc.subjectOsteopontinaspa
dc.subjectCiclooxigenasa-2spa
dc.titleExpresión de Osteopontina y Ciclooxigenasa-2 en relación con la proliferación celular, en mucosa colónica no tumoral, adenomas y adenocarcinoma de colon.spa
dc.title.translatedExpression of Osteopontin and Cyclooxygenase-2 in relation to cellular proliferation, in non-tumor colonic mucosa, colonic adenomas and colon adenocarcinoma.eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85eng
dc.type.contentTexteng
dc.type.driverinfo:eu-repo/semantics/articleeng
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersioneng
dspace.entity.typePublication

Archivos

Colecciones

Revista Ciencias Biomédicas - Portal de Revistas

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Sede: Claustro de San Agustín, Centro Histórico, Calle de la Universidad Cra. 6 #36-100
Colombia, Bolívar, Cartagena
Ver más...

Línea de Atención

Línea Anticorrupción

Síguenos en: